共 50 条
Development of an LC-MS/MS method for quantification of kadsurenone in rat plasma and its application to a pharmacokinetic study
被引:2
|作者:
Zhang, Nan
[1
]
Li, Rui
[2
]
Yu, Haiyao
[3
]
Shi, Dan
[2
]
Dong, Ning
[1
]
Zhang, Sixi
[4
]
Wang, Helei
[5
]
机构:
[1] Jilin Univ, Hosp 1, Dept Emergency Med, Changchun 130021, Peoples R China
[2] Changchun Univ Chinese Med, Affiliated Hosp, Dept Emergency Med, Changchun 130021, Peoples R China
[3] Food & Drug Control Changchun, Changchun 130021, Peoples R China
[4] Jilin Univ, Hosp 1, Dept Pharm, Changchun 130021, Peoples R China
[5] Jilin Univ, Hosp 1, Dept Gastrointestinal Surg, Changchun 130021, Peoples R China
关键词:
kadsurenone;
Piper kadsura;
Alzheimer's disease;
pharmacokinetic;
rat plasma;
PLATELET-ACTIVATING-FACTOR;
PIPER-FUTOKADSURA;
INHIBITION;
D O I:
10.1002/bmc.2989
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
A sensitive and rapid LC-MS/MS method was developed and validated for the determination of kadsurenone in rat plasma using lysionotin as the internal standard (IS). The analytes were extracted from rat plasma with acetonitrile and separated on a SB-C-18 column (50x2.1mm, i.d.; 1.8 mu m) at 30 degrees C. Elution was achieved with a mobile phase consisting of methanol-water-formic acid (65:35:0.1, v/v/v) at a flow rate of 0.30mL/min. Detection and quantification for analytes were performed by mass spectrometry in the multiple reaction monitoring mode with positive electrospray ionization m/z at 357.1178.1 for kadsurenone, and m/z 345.1315.1 for IS. Calibration curves were linear over a concentration range of 4.88-1464ng/mL with a lower limit of quantification of 4.88ng/mL. The intra- and inter-day accuracies and precisions were <8.9%. The LC-MS/MS assay was successfully applied for oral pharmacokinetic evaluation of kadsurenone using the rat as an animal model. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:1754 / 1758
页数:5
相关论文